The Priority Review

Tag

Weekly issues

2 stories

  1. Clinical trials

    Atezolizumab, ibogaine, and GlaxoSmithKline: the issue of October 5, 2026

    The week of October 5 to 11, 2026: 44 briefs, 9 stories, led by atezolizumab, ibogaine, and GlaxoSmithKline.

  2. Clinical trials

    Eli Lilly and Company, Boehringer Ingelheim, and IgA Nephropathy: the issue of September 28, 2026

    The week of September 28 to October 4, 2026: 29 briefs, 3 stories, led by Eli Lilly and Company, Boehringer Ingelheim, and IgA Nephropathy.